Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jansen

Showing results (321-330 of 336) with videos related to

Pageof 34
Sort By:
Nature|July 31, 2020
Occupancy maps of 208 chromatin-associated proteins in one human cell typeE Christopher Partridge, Surya B Chhetri, Jeremy W Prokop, et al.
Human Mutation|January 1, 1996
Novel mutations and polymorphisms in the Fanconi anemia group C geneR A Gibson, N V Morgan, L H Goldstein, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibitionScott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Research Square|March 30, 2023
Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRSCaroline S Jansen, Roshan S Prabhu, Meghana S Pagadala, et al.
Molecular Therapy. Methods & Clinical Development|August 8, 2025
AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administrationJianan Wang, Timo Jonker, Aina Cervera-Barea, et al.
Nature|December 13, 2019
An intra-tumoral niche maintains and differentiates stem-like CD8 T cellsCaroline S Jansen, Nataliya Prokhnevska, Viraj A Master, et al.
Research Square|August 16, 2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Nature Cancer|February 27, 2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
The Journal of Clinical Investigation|September 4, 2025
Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibitionScott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Nature|June 15, 2022
An exercise-inducible metabolite that suppresses feeding and obesityVeronica L Li, Yang He, Kévin Contrepois, et al.
Pageof 34

Showing results (321-330 of 336) with videos related to

Sort By:
Pageof 34
Nature|July 31, 2020
Occupancy maps of 208 chromatin-associated proteins in one human cell typeE Christopher Partridge, Surya B Chhetri, Jeremy W Prokop, et al.
Human Mutation|January 1, 1996
Novel mutations and polymorphisms in the Fanconi anemia group C geneR A Gibson, N V Morgan, L H Goldstein, et al.
Medrxiv : the Preprint Server for Health Sciences|February 19, 2024
Localized high-risk prostate cancer harbors an androgen receptor low subpopulation susceptible to HER2 inhibitionScott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Research Square|March 30, 2023
Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRSCaroline S Jansen, Roshan S Prabhu, Meghana S Pagadala, et al.
Molecular Therapy. Methods & Clinical Development|August 8, 2025
AAV6 vectors provide superior gene transfer compared to AAV9 vectors following intramyocardial administrationJianan Wang, Timo Jonker, Aina Cervera-Barea, et al.
Nature|December 13, 2019
An intra-tumoral niche maintains and differentiates stem-like CD8 T cellsCaroline S Jansen, Nataliya Prokhnevska, Viraj A Master, et al.
Research Square|August 16, 2024
Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
Nature Cancer|February 27, 2025
Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trialMehmet A Bilen, BaoHan T Vo, Yuan Liu, et al.
The Journal of Clinical Investigation|September 4, 2025
Localized high-risk prostate cancer harbors an androgen receptor activity-low subpopulation susceptible to HER2 inhibitionScott Wilkinson, Anson T Ku, Rosina T Lis, et al.
Nature|June 15, 2022
An exercise-inducible metabolite that suppresses feeding and obesityVeronica L Li, Yang He, Kévin Contrepois, et al.
Pageof 34